Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06877858Phase 1Recruiting
Phase 1, randomised, double-blind trial of methadone in opioid use disorder (OUD) (2 arms). Primary endpoint: Dose-limiting toxicity rate at 24 hours. Started Sep 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06877858.